Spastic Cerebral Palsy. Cerebral Palsy , Unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Spastic cerebral palsy (Diparetic , Quadriparetic) Ages between 4 - 14 years Gross motor function classification (GMFC) between 2 -5 No seizure disorder or with controlled seizure Evidence of definite acquired abnormal imaging findings compatible with Cerebral Palsy Informed consent taken from their parents
Exclusion criteria
Exclusion criteria: Normal brain MRI Progressive neurological diseases ( for example leukodystrophy or neurometabolic disorders) Congenital Cortical malformations Toxoplasmosis Others Rubella Cytomegalovirus Hepatitis (TORCH) infections Other types of cerebral palsy including athetoid , atonic , ataxic , and mixed type Acute intercurrent infections such as Hepatitis C Virus ( HCV), Hepatitis B Virus (HBV) ,Human Immunodeficiency Virus (HIV) Hemorrhagic diathesis Severe anemia ( Hemoglobin less than 8 ) Ventilator dependent pulmonary diseases Renal insufficiency Severe liver dysfunction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Motor development alteration with GMFM 66 score. Timepoint: Before intervention , 1 month after intervention , 3 months after intervention ,6 months after intervention , 12 months after intervention. Method of measurement: questionairre.;Change of motor function with GMFCS score. Timepoint: Before intervention , 1 month after intervention , 3 months after intervention ,6 months after intervention , 12 months after intervention. Method of measurement: questionairre.;Spasticity change of patients according to Ashworth scale. Timepoint: Before intervention , 1 month after intervention , 3 months after intervention ,6 months after intervention , 12 months after intervention. Method of measurement: questionairre.;Developmental status according to Stanford Binet test. Timepoint: Before intervention , 1 month after intervention , 3 months after intervention ,6 months after intervention , 12 months after intervention. Method of measurement: questionairre. | — |
Secondary
| Measure | Time frame |
|---|---|
| Probable Change of brain lesions. Timepoint: Before intervention , 1 year after intervention. Method of measurement: Brain Magnetic Resonance Imaging (MRI) , Brain Magnetic Resonance Spectroscopy (MRS) , Brain Deep Tensor Imaging (DTI).;Fever. Timepoint: 24 hours after intervention , 48 hours after intervention , 72 hours after intervention. Method of measurement: Axillary thermometer.;Meningitis. Timepoint: First 3 days after intervention or any time after intervention. Method of measurement: Lumbar Puncture.;Hyper sensitivity reactions. Timepoint: First week after intervention. Method of measurement: Physical exam. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences